Feng et al. [166] have hypothesized that COUP-TFII might be an oncogene given its significant up-regulation in primary cancers compared to normal tissues and the overall shorter survival of patients with elevated COUP-TFII expression. This evidence concerns the gene NR2F2 and cancer.